Psychedelic Stock Deep Dive: Atai Life Sciences [Seeking Alpha]
ATAI Life Sciences N.V. - Common Shares (ATAI)
US:NASDAQ Investor Relations:
ir.atai.net.cn
Company Research
Source: Seeking Alpha
Summary After the FDA's rejection of Lykos Therapeutics' NDA for MDMA therapy, we take a more complete look at major psychedelic stocks. Atai Life Sciences is an early mover with a unique company structure and diverse pipeline that could minimize risk. Atai's stock is at historic lows, but with several upcoming Phase 2 milestones, a long-term position in ATAI could be a smart move. Alistair Berg With the FDA's recent rejection of Lykos Therapeutics' New Drug Application for MDMA therapy, investors are wondering which psychedelic stocks are best positioned to survive and thrive after the FDA's decision. As mentioned in previous psychedelic stock coverage , the FDA's rejection of MDMA therapy in its current form doesn't doom MDMA as a future therapy, nor does it necessarily hurt other psychedelic medicine firms. If anything, the FDA's decision could potentially bestow some advantages to other top psychedelic stocks. We'll dig a little deeper with a more complete look at the
Show less
Read more
Impact Snapshot
Event Time:
ATAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATAI alerts
High impacting ATAI Life Sciences N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
ATAI
News
- atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswire
- atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewswire
- atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)GlobeNewswire
- atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth ConferenceGlobeNewswire
- Meet The Crypto-Pioneering, Biohacking, Psychedelic-Promoting Billionaire Who Wants To Reimagine The Olympics [Forbes]Forbes
ATAI
Earnings
- 8/13/24 - Miss
ATAI
Sec Filings
- 8/14/24 - Form 8-K
- 8/13/24 - Form 10-Q
- 8/13/24 - Form 8-K
- ATAI's page on the SEC website